Allos Therapeutics Completes Patient Enrollment in Pivotal Phase 3 Study of EFAPROXYN(TM) in Women with Brain Metastases Originating from Breast Cancer - Instablogs
Allos Therapeutics Completes Patient Enrollment in Pivotal Phase 3 Study of EFAPROXYN(TM) in Women with Brain Metastases Originating from Breast Cancer
Pooja , Shimla: Aug 29 2006
Made Popular Aug 29 2006
Allos Therapeutics has announced that it has completed patient enrollment in its pivotal Phase 3 ENRICH study of EFAPROXYN(TM) (efaproxiral) in women with brain metastases originating from breast cancer. ENhancing whole brain Radiation therapy In...
Read Story
Tags: Health And Care, Health & Fitness
Add Images and Videos
Close X
Recommended Tags or Keywords
Search by Tags or Keywords
Selected Media ( You can Upload only Six media )
Add to Story
Sorry no picture found for this combination of tags. Try to search minimum number of tags at once
Add your Comment
FAQ / Help
Move to top